The approval of Calquence marks the first and only BTK inhibitor approved for the first-line treatment of MCL in the US.

The other types including mantle cell lymphoma, diffuse large B-cell lymphoma ... or conjunctival malignant melanoma, additional lymph node resection should be considered when planning exenteration.

Core needle biopsy (CNB) has become an increasingly popular method for diagnosing lymphoma, a type of cancer ... that involves removing an entire lymph node or a larger tissue sample for examination.

The descriptive term AtLP may be used as an interim label when morphologic and molecular features are not sufficient to render a positive diagnosis of lymphoma. The development of AtLP may also ...

T-cell lymphoma is a type of lymphatic cancer that starts in the T lymphocytes (T cells), a type of white blood cell. T lymphocytes (T cells) and B lymphocytes (B cells) are two types of white blood ...

Early involvement of the bone marrow also is more typical of leukemia. Lymphoma is usually diagnosed with a lymph node or bone marrow biopsy. Imaging and other tests help healthcare providers ...

Actress Susan Sullivan, 82, who announced she was “cancer-free” from non-small cell lung cancer (the most common type of lung cancer) last year, is now battling lymphoma ... a swollen lymph node under ...

The Food and Drug Administration (FDA) has granted traditional approval to Calquence (acalabrutinib) with bendamustine and Rituxan (rituximab) for adults with previously untreated mantle cell lymphoma ...

The agency also approved acalabrutinib as part of combination therapy for mantle cell lymphoma. The FDA approved two oncology regimens on Jan. 16. One is for a subset of patients with colorectal ...

for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous hematopoietic stem cell transplantation. This decision, announced today ...